 6. Any patient with a significant medical condition which is thought unlikely to tolerate the therapies. Such as cardiac disease e.g. symptomatic coronary artery disease or myocardial infarction within last 12 months, clinically-significant lung disease, clinically-significant bone marrow, liver, renal function disorder; 